Chong Kun Dang Pharmaceutical

This study tested two similar immunosuppressant drugs, MYREPTIC-N® and MY-REPT®, in 158 adults who had a kidney transplant at least a year ago. The goal was to see how well each drug prevented organ rejection, graft loss, or death. Participants continued their usual anti-rejectio…

This study looked at how a tacrolimus tablet (TacroBell) works in 128 kidney transplant patients. The goal was to measure drug levels and how well patients tolerate it. Participants were adults receiving a kidney from a deceased or living donor. The results help doctors understan…

This study tested a drug called CertiroBell® against a standard medicine (mycophenolate mofetil) in 150 adults who received a liver transplant from a living donor. The goal was to see if CertiroBell could better prevent serious problems like organ rejection, graft loss, or death.…

This study tested a new treatment called CKD-981 to see if it can safely and temporarily ease knee pain in people with osteoarthritis. About 100 adults aged 40 to 80 with moderate knee pain took part. The treatment was compared to a fake procedure (sham) to measure its true effec…

This study looked at how a new drug combination called CKD-383 is absorbed and processed in the body. It involved 31 healthy adults who took the drug either as a single combined pill or as separate pills. The goal was to compare the two ways of taking the medication, not to treat…

This early-stage study tested the safety of a new drug called CKD-508 in 44 healthy adults aged 18 to 55. Participants received either the drug or a placebo once daily, and researchers monitored side effects and how the drug moved through the body. The goal was to gather safety a…

This study looked at how a new combination diabetes drug, CKD-383, moves through the body compared to taking the individual drugs separately. It involved 30 healthy adults who received a single dose of each treatment in a random order. The goal was to measure drug levels and chec…

This early-stage study looked at how a new combination diabetes drug, CKD-383, is processed by the body and whether it is safe. Thirty healthy adults took the drug as two tablets together or separately in a random order. The goal was to compare the two ways of taking the medicati…

This early-stage study tested a new drug called CKD-846 in 31 healthy men to see how the body processes it and if it is safe. The goal was to gather information, not to treat the condition. Participants were healthy men aged 19 to 55 who agreed to use contraception.

This study looked at how a new drug called CKD-508 interacts with two other medicines (midazolam and rosuvastatin) in 24 healthy adult men. The goal was to measure drug levels in the blood, not to treat any disease. It helps researchers understand safe dosing for future studies.